Etsuko Iio
Kumamoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Rifaximin Improves Cognitive Performance and Reduces Cirrhosis-Related Adverse Events in Covert Hepatic Encephalopathy: A Randomized Controlled Trial.
Journal: Alimentary pharmacology & therapeutics
Published: January 25, 2026
Mendelian Randomization Using a Japanese GWAS Identifies an HLA-Linked Causal Effect of Chronic Hepatitis B on Cholangiocarcinoma Risk.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: December 02, 2025
Impact of Etiological Shifts and the Rising Burden of Non-B Non-C Hepatocellular Carcinoma on Surveillance and Prognosis: Insights From a 20-Year Retrospective Observational Study.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: November 20, 2025
TP53 mutation predicts resistance to immune checkpoint inhibitor-based therapy in intrahepatic cholangiocarcinoma.
Journal: Journal of gastroenterology
Published: July 28, 2025
Innovative Hepatitis C Screening: Clinical Utility of the HCV Antigen-Antibody Assay in Japan.
Journal: Japanese journal of infectious diseases
Published: April 29, 2025
Restoration of the gut-microbiota-liver axis after hepatitis C virus eradication.
Journal: JHEP reports : innovation in hepatology
Published: February 04, 2025
Serum alpha-fetoprotein/hepatocyte growth factor ratio as a novel biomarker predicting the prognosis of acute alcoholic hepatitis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: December 23, 2024
MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents.
Journal: Journal of gastroenterology
Published: February 27, 2024
Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents.
Journal: Oncology
Published: December 08, 2023
Randomized phase I/II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinoma.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: August 16, 2023
Serum inducible protein 10 kDa/C-X-C motif chemokine 10 levels predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: January 27, 2023
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study.
Journal: Hepatology international
Published: November 22, 2022
Last Updated: 09/26/2026